Organ Donation in Modern Clinical Practice

Organ Donation in Modern Clinical Practice: A Comprehensive Review for Internal Medicine Residents

 Dr Neeraj Manikath ,claude.ai

Abstract

Organ donation represents a critical component of contemporary healthcare, offering life-saving interventions for patients with end-stage organ failure. This review examines the current landscape of organ donation with particular focus on brain death criteria, family discussions, and donation pathways. Understanding these concepts is essential for internal medicine residents who frequently encounter situations where organ donation becomes a consideration. This article provides evidence-based guidelines for approaching these sensitive discussions and understanding the clinical, ethical, and practical aspects of the organ donation process.

Introduction

Organ transplantation has evolved dramatically since the first successful kidney transplant in 1954, with over 175,000 people currently awaiting organ transplants in the United States alone.[1] Despite advances in transplantation medicine, organ shortages persist as a significant public health challenge, with approximately 17 patients dying daily while awaiting transplantation.[2] Internal medicine residents play a pivotal role in the initial identification of potential donors and in facilitating discussions with families regarding donation options.

Brain Death: Definition and Diagnostic Criteria

Brain death is defined as the irreversible cessation of all functions of the entire brain, including the brainstem.[3] This concept forms the foundation for deceased organ donation in many jurisdictions and requires precise clinical determination.

Evolution of Brain Death Criteria

The concept of brain death was first formalized in 1968 by the Harvard Medical School Committee, which established criteria to define irreversible coma.[4] These criteria have evolved through subsequent refinements by organizations including the American Academy of Neurology (AAN) and the World Brain Death Project.[5,6]

Current Diagnostic Approach

The diagnosis of brain death involves a systematic process that includes:

1. Establishing Irreversible and Proximate Cause: Documentation of a clear etiology capable of causing brain death, such as traumatic brain injury, intracranial hemorrhage, or anoxic injury.[6]

2. Excluding Confounders: Elimination of conditions that might confound the neurological examination, including:

   • Severe electrolyte, acid-base, or endocrine disturbances
   • Core temperature < 36°C (or 32°C in some guidelines)
   • Hypotension (systolic blood pressure < 100 mmHg)
   • Presence of CNS-depressant drugs or neuromuscular blocking agents[7]

3. Clinical Examination: Demonstration of:

   • Coma (unresponsiveness to all stimuli)
   • Absence of brainstem reflexes:
     • Pupillary light reflexes
     • Corneal reflexes
     • Oculocephalic and oculovestibular reflexes
     • Gag and cough reflexes
   • Apnea (confirmed by apnea testing)[8]

4. Ancillary Testing: When clinical examination or apnea testing cannot be completed or when required by institutional policy or law:

   • Cerebral angiography
   • Nuclear brain scan
   • Transcranial Doppler ultrasonography
   • Electroencephalography
   • CT angiography[9]

5. Observation Period: Variable by jurisdiction and institutional policy; typically 6-24 hours, particularly in cases of hypoxic-ischemic encephalopathy.[10]

Approaching Families About Organ Donation

Timing of Discussions

Research demonstrates that separation of the notification of death (or brain death) from the request for organ donation improves consent rates.[11] The "decoupling" approach allows families time to process the loss before considering donation decisions.

Collaborative Approach

Best practices involve collaboration between the treating clinical team and organ procurement organization (OPO) coordinators:

1. Initial Discussion: The treating physician should inform the family about brain death or imminent death.

2. Referral to OPO: Early notification of the OPO allows coordinators to evaluate potential donor suitability before approaching families.[12]

3. Donation Request: Ideally conducted as a collaborative discussion involving both the treating team and trained OPO coordinators.[13]

Communication Strategies

Effective communication includes:

1. Clear Language: Using precise terminology such as "brain death" rather than ambiguous phrases like "life support."[14]

2. Cultural Sensitivity: Acknowledging and respecting cultural and religious perspectives regarding death and donation.[15]

3. Family-Centered Approach: Allowing adequate time for questions and providing comprehensive information about the donation process.[16]

4. Psychological Support: Ensuring ongoing support for families regardless of their decision regarding donation.[17]

Types of Organ Donation

Donation After Brain Death (DBD)

Historically the primary pathway for deceased organ donation, DBD involves procurement of organs after declaration of brain death while cardiovascular function is maintained through mechanical support.[18]

Advantages:

• Multiple organs can typically be recovered
• Better organ perfusion until recovery
• Generally higher success rates for certain organs (hearts, lungs)[19]

Donation After Circulatory Death (DCD)

An increasingly important pathway involving donation after cessation of circulatory function in patients who do not meet brain death criteria but for whom continued life-sustaining treatment is deemed futile.[20]

Categories of DCD (Modified Maastricht Classification):

1. Controlled DCD (Category III): Planned withdrawal of life-sustaining therapy with anticipated cardiac arrest
2. Uncontrolled DCD (Categories I, II, IV, V): Unexpected cardiac arrest with failed resuscitation[21]

Considerations:

• Warm ischemia time impacts organ viability
• Typically limited to kidneys, liver, and occasionally lungs
• Requires precise protocols for withdrawal of care and declaration of death[22]

Living Donation

Involves donation of kidneys, liver segments, lung lobes, or portions of pancreas or intestine from living donors.[23]

Considerations:

• Extensive donor evaluation required
• Ethical considerations regarding informed consent and coercion prevention
• Specialized protocols for paired and chain donations[24]

Medical Management of Potential Organ Donors

Physiologic Changes After Brain Death

Brain death triggers a cascade of physiologic derangements including:

• Hemodynamic instability
• Diabetes insipidus
• Hypothermia
• Coagulopathy
• Pulmonary edema
• Hormonal dysfunction[25]

Management Goals

1. Hemodynamic Stability:

   • MAP target: 60-100 mmHg
   • CVP: 6-10 mmHg
   • Use of vasopressors as needed (preference for vasopressin and norepinephrine)[26]

2. Ventilatory Management:

   • Lung-protective ventilation strategies
   • Tidal volume: 6-8 mL/kg
   • PEEP: 5-10 cmH2O
   • PaO2 > 100 mmHg, PaCO2 35-45 mmHg[27]

3. Hormone Replacement:

   • Methylprednisolone (15 mg/kg q24h)
   • Vasopressin (0.5-4.0 U/h)
   • Insulin (for glucose control)
   • Consider thyroid hormone replacement[28]

4. Temperature Regulation:

   • Maintain core temperature > 35°C[29]

Ethical Considerations

Respect for Autonomy

Respecting the deceased's documented wishes regarding donation through advance directives, donor registries, or driver's license designations.[30]

Dead Donor Rule

The principle that organ removal should not cause death, requiring donors to be declared dead before procurement.[31]

Conflicts of Interest

Ensuring clear separation between the treating team determining brain death and the transplant team.[32]

Resource Allocation

Balancing individual patient care with the societal benefit of organ availability.[33]

Legal Framework

Uniform Determination of Death Act (UDDA)

Provides legal foundation for brain death determination in the United States.[34]

Consent Frameworks

Most jurisdictions follow either:

• Opt-in Systems: Requiring explicit consent for donation (U.S., U.K., Canada)
• Opt-out Systems: Presuming consent unless explicitly refused (Spain, Austria, Belgium)[35]

Required Referral Laws

Many jurisdictions mandate notification of OPOs for all deaths and imminent deaths.[36]

Special Considerations for Internal Medicine Residents

Role in Early Identification

Residents should recognize potential donors by:

• Identifying patients with devastating neurological injury
• Early notification of hospital-based donation teams or OPOs
• Understanding institutional protocols for referral[37]

Communication Skills Development

• Training in delivering bad news
• Practice in decoupled donation requests
• Cultural competency in end-of-life discussions[38]

Documentation Requirements

• Accurate recording of brain death determination
• Documentation of family discussions
• Proper consent documentation[39]

Future Directions

Normothermic Regional Perfusion

Emerging technique using extracorporeal membrane oxygenation to perfuse abdominal organs after circulatory death, potentially expanding the DCD donor pool.[40]

Ex Vivo Organ Perfusion

Technology allowing assessment and reconditioning of marginal organs outside the body before transplantation.[41]

Xenotransplantation

Recent advances in genetically modified porcine organs showing promise in addressing organ shortages.[42]

Conclusion

Organ donation represents a complex intersection of clinical medicine, ethics, law, and interpersonal communication. Internal medicine residents who develop competence in brain death determination and skillful family discussions about donation options contribute significantly to the transplantation system. Understanding the nuances of different donation pathways and the medical management of potential donors enables residents to provide optimal end-of-life care while respecting the opportunity for donation when appropriate.

References

1. United Network for Organ Sharing (UNOS). Transplant trends. 2023. Available at: https://unos.org/data/transplant-trends/

2. Organ Procurement and Transplantation Network (OPTN). National data. 2024. Available at: https://optn.transplant.hrsa.gov/data/

3. Wijdicks EFM. The diagnosis of brain death. N Engl J Med. 2021;384(23):2211-2223.

4. A definition of irreversible coma. Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. JAMA. 1968;205(6):337-340.

5. Quality Standards Subcommittee of the American Academy of Neurology. Practice parameters for determining brain death in adults (summary statement). Neurology. 1995;45(5):1012-1014.

6. Greer DM, Shemie SD, Lewis A, et al. Determination of brain death/death by neurologic criteria: The World Brain Death Project. JAMA. 2020;324(11):1078-1097.

7. Nakagawa TA, Ashwal S, Mathur M, et al. Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations. Crit Care Med. 2011;39(9):2139-2155.

8. Wijdicks EFM, Varelas PN, Gronseth GS, Greer DM. Evidence-based guideline update: determining brain death in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(23):1911-1918.

9. Kramer AH. Ancillary testing in brain death. Semin Neurol. 2015;35(2):125-138.

10. Lewis A, Bakkar A, Kreiger-Benson E, et al. Determination of death by neurologic criteria in the United States: The Case for Revising the Uniform Determination of Death Act. J Law Med Ethics. 2020;48(1):115-128.

11. Simpkin AL, Robertson LC, Barber VS, Young JD. Modifiable factors influencing relatives' decision to offer organ donation: systematic review. BMJ. 2009;338:b991.

12. Dominguez-Gil B, Murphy P, Procaccio F. Ten changes that could improve organ donation in the intensive care unit. Intensive Care Med. 2016;42(2):264-267.

13. Ebadat A, Brown CV, Ali S, et al. Improving organ donation rates by modifying the family approach process. J Trauma Acute Care Surg. 2014;76(6):1473-1475.

14. Siminoff LA, Mercer MB, Graham G, Burant C. The reasons families donate organs for transplantation: implications for policy and practice. J Trauma. 2007;62(4):969-978.

15. Oliver M, Woywodt A, Ahmed A, Saif I. Organ donation, transplantation and religion. Nephrol Dial Transplant. 2011;26(2):437-444.

16. de Groot J, van Hoek M, Hoedemaekers C, et al. Decision making on organ donation: the dilemmas of relatives of potential brain dead donors. BMC Med Ethics. 2015;16(1):64.

17. Kentish-Barnes N, Chevret S, Valade S, et al. A three-step approach to address family opposition to organ donation in brain-dead patients. Intensive Care Med. 2018;44(7):1147-1150.

18. Shemie SD, Baker AJ, Knoll G, et al. National recommendations for donation after cardiocirculatory death in Canada: Donation after cardiocirculatory death in Canada. CMAJ. 2006;175(8):S1.

19. Tullius SG, Rabb H. Improving the supply and quality of deceased-donor organs for transplantation. N Engl J Med. 2018;378(20):1920-1929.

20. Bernat JL, D'Alessandro AM, Port FK, et al. Report of a national conference on donation after cardiac death. Am J Transplant. 2006;6(2):281-291.

21. Thuong M, Ruiz A, Evrard P, et al. New classification of donation after circulatory death donors definitions and terminology. Transpl Int. 2016;29(7):749-759.

22. Manara AR, Murphy PG, O'Callaghan G. Donation after circulatory death. Br J Anaesth. 2012;108(suppl 1):i108-i121.

23. Lentine KL, Kasiske BL, Levey AS, et al. KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017;101(8S Suppl 1):S1-S109.

24. Butt Z, Dew MA, Liu Q, et al. Psychological outcomes of living liver donors from a multicenter prospective study: results from the Adult-to-Adult Living Donor Liver Transplantation Cohort Study2 (A2ALL-2). Am J Transplant. 2017;17(5):1267-1277.

25. Kotloff RM, Blosser S, Fulda GJ, et al. Management of the potential organ donor in the ICU: Society of Critical Care Medicine/American College of Chest Physicians/Association of Organ Procurement Organizations Consensus Statement. Crit Care Med. 2015;43(6):1291-1325.

26. Souter MJ, Eidbo E, Findlay JY, et al. Organ donor management: Part 1. Toward a consensus to guide anesthesia services during donation after brain death. Semin Cardiothorac Vasc Anesth. 2018;22(2):211-222.

27. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA. 2010;304(23):2620-2627.

28. Novitzky D, Mi Z, Sun Q, et al. Thyroid hormone therapy in the management of 63,593 brain-dead organ donors: a retrospective analysis. Transplantation. 2014;98(10):1119-1127.

29. Anderson TA, Bekker P, Vagefi PA. Anesthetic considerations in organ procurement surgery: a narrative review. Can J Anaesth. 2015;62(5):529-539.

30. Shaw DM. The consequences of vagueness in consent to organ donation. Bioethics. 2017;31(6):424-431.

31. Truog RD, Miller FG, Halpern SD. The dead-donor rule and the future of organ donation. N Engl J Med. 2013;369(14):1287-1289.

32. Lewis A, Greer D. Current controversies in brain death determination. Nat Rev Neurol. 2017;13(8):505-509.

33. Caplan A. Bioethics of organ transplantation. Cold Spring Harb Perspect Med. 2014;4(3):a015685.

34. Bernat JL. The whole-brain concept of death remains optimum public policy. J Law Med Ethics. 2006;34(1):35-43.

35. Arshad A, Anderson B, Sharif A. Comparison of organ donation and transplantation rates between opt-out and opt-in systems. Kidney Int. 2019;95(6):1453-1460.

36. Traino HM, Alolod GP, Shafer T, Siminoff LA. Interim results of a national test of the rapid assessment of hospital procurement barriers in donation (RAPiD). Am J Transplant. 2012;12(11):3094-3103.

37. Wojda TR, Stawicki SP, Yandle KP, et al. Keys to successful organ procurement: An experience-based review of clinical practices at a high-performing health-care organization. Int J Crit Illn Inj Sci. 2017;7(2):91-100.

38. Czerwinski J, Danek T, Trujnara M, et al. Organ donation educational initiatives: A cross-sectional survey among medical students in Poland. Transplant Proc. 2019;51(7):2195-2198.

39. Brierley J. Paediatric organ donation in the UK. Arch Dis Child. 2010;95(2):83-88.

40. Hessheimer AJ, Billault C, Barrou B, Fondevila C. Hypothermic or normothermic abdominal regional perfusion in controlling donation after circulatory determination of death donors. Curr Opin Organ Transplant. 2018;23(5):542-547.

41. Nasralla D, Coussios CC, Mergental H, et al. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018;557(7703):50-56.

42. Cooper DKC, Gaston R, Eckhoff D, et al. Xenotransplantation-the current status and prospects. Br Med Bull. 2018;125(1):5-14.